MRI-compatible technology out of Purdue University has the ability to detect and monitor cerebral vascular disorders and injuries without the use of potentially harmful contrast agents, the university announced this week.

Researchers have created a functional MRI (fMRI)-based analytical imaging method to detect and monitor blood vessel disorders and injuries in the brain without using invasive contrast agents.

PET imaging may better predict long-term benefits and guide discontinuation of therapy compared to standard contrast CT for patients with metastatic melanoma, according to findings presented at the 2018 American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

Research out of the University of California, Davis is offering insight into how toddlers form memories, marking the first study of its kind to shed light on how specific brain regions are activated during memory recall in 2-year-olds.

Women who underwent initial mammography screening were more likely to seek out additional preventative measures—despite a positive or negative result—such as Pap smear, bone mass measurement or influenza vaccine services.

Royal Philips announced Tuesday, June 5, that its Ingenia Elition 3.0T MR solution and two clinical applications, Philips Compressed SENSE and 3D APT, have received FDA approval.

Siemens Healthineers announced this week that its Biograph Vision PET/CT imaging system has gained FDA clearance.

Research presented June 1 at the 2018 American Society of Clinical Oncology (ASCO) annual meeting in Chicago may help extend survival rates in patients with esophageal cancer by utilizing positron emission tomography (PET), according to a news release from the University of Colorado Cancer Center.